Description
NA Semax (N-Acetyl Semax) is a modified analog of the ACTH (4–10) peptide fragment, developed to enhance stability and biological activity. Unlike full-length ACTH, NA Semax does not stimulate adrenal hormone production but is studied for its effects within the central nervous system. It is primarily researched for its nootropic, neuroprotective, and neuroregulatory properties.
Research suggests NA Semax may influence the expression of brain-derived neurotrophic factor (BDNF), a key protein involved in synaptic plasticity, learning, memory formation, and neuronal survival. It has also been studied for its potential to modulate dopaminergic and serotonergic pathways, contributing to improved mental clarity, cognitive performance, and stress adaptation.
In research models, NA Semax has shown promise in supporting recovery following neurological stress, ischemic events, and cognitive decline. Its mechanisms are believed to involve regulation of gene expression and neurotrophic signaling rather than direct stimulation.
NA Semax is commonly studied via intranasal administration, with subcutaneous use less frequently reported in research settings. It is not classified as a hormone or stimulant and is investigated for regulatory and neuroprotective support.


Reviews
There are no reviews yet.